Accelerant Holdings (FRA:GL4) Research & Development: €0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:GL4 Accelerant Holdings FRA:GL4
12 GF Score
Price €17.00
! 3 Warning Signs
View Full Analysis

What is Accelerant Holdings Research & Development?

Accelerant Holdings FRA:GL4 -0.59% 12 Research & Development is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:GL4 with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Accelerant Holdings's Research & Development for the three months ended in Jun. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was €0.0 Mil.

Accelerant Holdings  (FRA:GL4) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Accelerant Holdings Research & Development Related Terms

Accelerant Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Accelerant Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accelerant Holdings Research & Development Chart

Accelerant Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

Accelerant Holdings Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:GL4
12GF Score
Accelerant Holdings FRA:GL4
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accelerant Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Accelerant Holdings (FRA:GL4) has a Research & Development of €0.0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Accelerant Holdings and its competitors.
Is Accelerant Holdings' Research & Development too high?
Accelerant Holdings' current Research & Development is €0.0 Mil. Overall, Accelerant Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Accelerant Holdings' Research & Development compare to BWIN and NP?
Accelerant Holdings' Research & Development of €0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Accelerant Holdings and its competitors. Accelerant Holdings's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accelerant Holdings stock overvalued right now?
Accelerant Holdings (FRA:GL4) has a current Research & Development of €0.0 Mil. The current Research & Development is €0.0 Mil. Accelerant Holdings' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Accelerant Holdings (FRA:GL4), the current Research & Development is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accelerant Holdings Business Description

Other Exchanges ARX:USA
Address c/o Accelerant Re (Cayman) Ltd, West Bay Road, Unit 106, Windward 3, Regatta Office Park, Grand Cayman, CYM, KY1-1108
Accelerant Holdings operates as a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners. The company operates in three segments: Exchange Services, MGA Operations, and Underwriting. The majority of its revenue is generated from the Underwriting segment, which contains all revenue and expenses associated with the underwriting of insurance policies and assumption of reinsurance policies issued or accepted by Accelerant's consolidated insurance and reinsurance companies. Geographically, it operates in North America, the UK, and the EU, out of which it derives maximum revenue from North America.
12GF Score

Get the complete analysis for FRA:GL4

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.00
Price